Tenderwize
Retour à la recherche

Open House Discount Agreement for Urapidil

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 131 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Urapidil, ATC C02CA06

60/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

20 / 100

Facteurs de risque

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Pharmaceutical products with active ingredient Urapidil (ATC C02CA06)
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Afficher le résumé complet

Open house non-exclusive discount agreement for the active ingredient Urapidil (ATC C02CA06) under German social code SGB V. Contract period 01.05.2025–30.04.2027 with rolling enrollment. No competitive selection; all eligible pharmaceutical companies can join. No estimated value provided. EU funding flag inconsistent (structured data: true, XML notice: false). Electronic submission not allowed.

Risques

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Pharmaceutical company must be a 'pharmazeutischer Unternehmer' authorized to market Urapidil products in Germany
  • Drugs must be authorized and marketable in Germany (listed in Lauer-Taxe or verified via AMIce database)

Administrative

  • Submission of signed contract documents, proof of marketability, and authorization evidence

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreement for Urapidil

Non-exclusive discount contract for Urapidil pharmaceuticals. Uniform terms, no negotiations. Contracts run up to 24 months, ending no later than 30.04.2027. First enrollment deadline 31.03.2025 for start 01.05.2025. Subsequent enrollments possible each month.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
162677-2025

Documents (1)

Appels d'offres similaires